Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Toshikage Nagao

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
Plos One|November 22, 2013
Inhibition of the PI3K/Akt/GSK3 pathway downstream of BCR/ABL, Jak2-V617F, or FLT3-ITD downregulates DNA damage-induced Chk1 activation as well as G2/M arrest and prominently enhances induction of apoptosisTetsuya Kurosu, Toshikage Nagao, Nan Wu, et al.
International Journal of Oncology|December 13, 2012
PECAM-1 is involved in BCR/ABL signaling and may downregulate imatinib-induced apoptosis of Philadelphia chromosome-positive leukemia cellsNan Wu, Tetsuya Kurosu, Gaku Oshikawa, et al.
Plos One|November 17, 2011
DNA damage stress and inhibition of Jak2-V617F cause its degradation and synergistically induce apoptosis through activation of GSK3βToshikage Nagao, Gaku Oshikawa, Nan Wu, et al.
The Journal of Biological Chemistry|July 20, 2011
c-Cbl and Cbl-b ligases mediate 17-allylaminodemethoxygeldanamycin-induced degradation of autophosphorylated Flt3 kinase with internal tandem duplication through the ubiquitin proteasome pathwayGaku Oshikawa, Toshikage Nagao, Nan Wu, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|January 31, 2006
[Acquired hemophilia developing after treatment of idiopathic interstitial pneumonia]Toshikage Nagao, Koh Yamamoto, Asako Kitano, et al.
Anticancer Research|September 15, 2019
Soluble Interleukin-2 Receptor Level at Diagnosis Predicts Prognosis of Patients With Follicular Lymphoma Irrespective of Initial Management StrategyMasahide Yamamoto, Keisuke Tanaka, Yoshihiro Umezawa, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|November 9, 2020
[Impaired hematopoiesis due to copper deficiency in a hemodialysis patient supplemented with zinc]Satoshi Koi, Kosuke Arai, Ayako Nogami, et al.
International Journal of Molecular Sciences|October 16, 2024
Targeting USP14/UCHL5: A Breakthrough Approach to Overcoming Treatment-Resistant FLT3-ITD-Positive AMLAyako Nogami, Hideki Jose Amemiya, Hiroki Fujiwara, et al.
Frontiers in Immunology|July 23, 2024
An early regulatory mechanism of hyperinflammation by restricting monocyte contributionMegumi Akiyama, Masashi Kanayama, Yoshihiro Umezawa, et al.
Oncology Letters|July 12, 2017
Acute myeloid leukemia with t(3;21)(q26.2;q22) developing following low-dose methotrexate therapy for rheumatoid arthritis and expressing two AML1/MDS1/EVI1 fusion proteins: A case reportKeisuke Tanaka, Gaku Oshikawa, Hiroki Akiyama, et al.
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Plos One|November 22, 2013
Inhibition of the PI3K/Akt/GSK3 pathway downstream of BCR/ABL, Jak2-V617F, or FLT3-ITD downregulates DNA damage-induced Chk1 activation as well as G2/M arrest and prominently enhances induction of apoptosisTetsuya Kurosu, Toshikage Nagao, Nan Wu, et al.
International Journal of Oncology|December 13, 2012
PECAM-1 is involved in BCR/ABL signaling and may downregulate imatinib-induced apoptosis of Philadelphia chromosome-positive leukemia cellsNan Wu, Tetsuya Kurosu, Gaku Oshikawa, et al.
Plos One|November 17, 2011
DNA damage stress and inhibition of Jak2-V617F cause its degradation and synergistically induce apoptosis through activation of GSK3βToshikage Nagao, Gaku Oshikawa, Nan Wu, et al.
The Journal of Biological Chemistry|July 20, 2011
c-Cbl and Cbl-b ligases mediate 17-allylaminodemethoxygeldanamycin-induced degradation of autophosphorylated Flt3 kinase with internal tandem duplication through the ubiquitin proteasome pathwayGaku Oshikawa, Toshikage Nagao, Nan Wu, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|January 31, 2006
[Acquired hemophilia developing after treatment of idiopathic interstitial pneumonia]Toshikage Nagao, Koh Yamamoto, Asako Kitano, et al.
Anticancer Research|September 15, 2019
Soluble Interleukin-2 Receptor Level at Diagnosis Predicts Prognosis of Patients With Follicular Lymphoma Irrespective of Initial Management StrategyMasahide Yamamoto, Keisuke Tanaka, Yoshihiro Umezawa, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|November 9, 2020
[Impaired hematopoiesis due to copper deficiency in a hemodialysis patient supplemented with zinc]Satoshi Koi, Kosuke Arai, Ayako Nogami, et al.
International Journal of Molecular Sciences|October 16, 2024
Targeting USP14/UCHL5: A Breakthrough Approach to Overcoming Treatment-Resistant FLT3-ITD-Positive AMLAyako Nogami, Hideki Jose Amemiya, Hiroki Fujiwara, et al.
Frontiers in Immunology|July 23, 2024
An early regulatory mechanism of hyperinflammation by restricting monocyte contributionMegumi Akiyama, Masashi Kanayama, Yoshihiro Umezawa, et al.
Oncology Letters|July 12, 2017
Acute myeloid leukemia with t(3;21)(q26.2;q22) developing following low-dose methotrexate therapy for rheumatoid arthritis and expressing two AML1/MDS1/EVI1 fusion proteins: A case reportKeisuke Tanaka, Gaku Oshikawa, Hiroki Akiyama, et al.
Pageof 4